Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001140361-24-007732
Filing Date
2024-02-14
Accepted
2024-02-14 08:55:17
Documents
1
Group Members
NICHOLAS MAOUNIS

Document Format Files

Seq Description Document Type Size
1 SC 13G ef20021522_sc13g.htm SC 13G 90847
  Complete submission text file 0001140361-24-007732.txt   92702
Mailing Address THREE BALA PLAZA EAST. SUITE 506 BALA CYNWYD PA 19004
Business Address THREE BALA PLAZA EAST. SUITE 506 BALA CYNWYD PA 19004 844-511-9056
Larimar Therapeutics, Inc. (Subject) CIK: 0001374690 (see all company filings)

EIN.: 203857670 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-88225 | Film No.: 24632721
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address ONE AMERICAN LANE GREENWICH CT 06831
Business Address ONE AMERICAN LANE GREENWICH CT 06831 203-742-7740
Verition Fund Management LLC (Filed by) CIK: 0001454027 (see all company filings)

EIN.: 262472334 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G